Dianthus Therapeutics, Inc. (DNTH)
87.56
+1.36
(+1.58%)
USD |
NASDAQ |
Apr 08, 16:00
87.56
0.00 (0.00%)
After-Hours: 19:26
Dianthus Therapeutics Profit Margin (Quarterly) : -22.69K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -18.24% |
| Sarepta Therapeutics, Inc. | -93.07% |
| Daré Bioscience, Inc. | -140.8% |
| Relmada Therapeutics, Inc. | -- |
| Viridian Therapeutics, Inc. | -77.26K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -40.10% |
| Return on Assets | -37.62% |
| Return on Invested Capital | -39.97% |
| Gross Profit Margin (Quarterly) | 65.85% |
| Operating Margin (Quarterly) | -24.49K% |
| Return on Net Operating Assets | -1.86K% |